Regulatory features of the epidermal growth factor receptor
โ Scribed by Gordon N. Gill; June B. Santon; Paul J. Bertics
- Publisher
- John Wiley and Sons
- Year
- 1987
- Tongue
- English
- Weight
- 620 KB
- Volume
- 133
- Category
- Article
- ISSN
- 0021-9541
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Institute for Diabetes and Endocrinology, La lolla, California 92(1.?7 Treatment of Swiss 3T3 fibroblasts with basic fibroblast growth factor (bFGF) lead to a rapid reduction in epidermal growth factor (EGF) binding and a slower inhibition of EGF receptor autophosphorylation. The reduction in bindi
Previous results have shown that tumor promoters modify the properties of the epidermal growth factor (EGF) receptor through the activation of protein kinase C . Diacylglycerol-generating factors such as platelet-derived growth factor (PDGF) and p28"' should activate protein kinase C and alter EGF r
The receptor for epidermal growth factor (EGF) is a glycosylated transmembrane phosphoprotein that exhibits EGF-stimulable protein tyrosine kinase activity. On EGF stimulation, the receptor undergoes a self-phosphorylation reaction at tyrosine residues located primarily in the extreme carboxyl-termi